CLINICAL_TRIALS
trial_result
· 2021-07-29
Clinical Trial Update: A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 [Phase 3]
Summary
A Phase 3 study of relamorelin in diabetic gastroparesis was terminated; results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Gastroparesis, Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2021-07-29